Following integrin engagement or ligand stimulation, FAK forms a complex with SRC and triggers the activation of downstream pathways involved in tumor cell migration, invasion, survival, and immune suppression [27, 30, 32, 33]. The gene discussed is PTK2; the disease is neoplasm.